What you need to know The prevalence of heart failure across Europe is estimated to be 1-2% of adults.1 In the UK, this places a substantial burden on patients and healthcare resources, including ...

Panelists discuss how quality metrics should focus on keeping patients out of hospitals through core medical therapies, measuring all-cause hospitalizations and days spent at home in the community, ...

Larry Allen, MD, MHS, and Kenneth B Margulies, MD, discuss HF management for American Heart Month and Heart Failure Awareness Week. Advances in heart failure research and management have led to ...

Cutting-edge science and stimulating discussions in heart failure management are in store at Heart Failure 2024, a scientific congress of the European Society of Cardiology (ESC). Heart Failure is the ...

Despite substantial advances in guideline-directed medical therapy, recurrent hospitalization remains a persistent challenge in the management of congestive heart failure (CHF). Fluid overload is ...

You've probably heard or read about congestive heart failure. Maybe you've even been told you have it, or know someone who has. In the future, however, you may not encounter the "congestive" part of ...

Aaron M Wolfson, MD, and Sarah J Goodlin, MD, discuss nonpharmacologic interventions for patients with heart failure. Despite significant advances in the pharmacologic management of individuals with ...

Guidelines on heart failure (HF) stress the importance of lifestyle advice, although there is little evidence that such recommendations improve symptoms or prognosis. Patients experience symptoms of ...

Naples Comprehensive Health (NCH) today announced plans to expand its premier cardiovascular service to include the foundation of an Advanced Heart Failure and Transplant program, reinforcing its ...

Characterized by weakened or damaged heart musculature, heart failure results in the gradual buildup of fluid in a patient's lungs, legs, feet, and other parts of the body. The condition is chronic ...

This is a video synopsis/summary of a panel discussion involving Robert Groves, MD, executive vice president and chief medical officer, Banner |Aetna; Eugene E. Wright Jr, MD, consulting associate, ...